Orchid Pharma Ltd. Fundamental & Technical Research, Share Price Today

NSE : ORCHPHARMA
NIFTY : Nifty Microcap 250

About Company

Orchid Pharma (Orchid), established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. The company enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms. The company has globally present through alliances and partnerships with globally reputed majors.

Market Cap. ₹3,654 Cr.

52 Week - High/Low ₹1,997/718

P/E Ratio 32.22

P/B Ratio 3.00

Enterprise Value ₹3,521 Cr.

ROE % 9.72

RSI Value 26.16

EMA 50 1010.03

EMA 200 1228.06

Net Profit 95 Cr.

Net Profit 3year growth -180.88 Cr.

Net Profit 3 year (back) -117 Cr.

Debt to Equity 0.11 %

EPS Growth TTM -23.82 %

Current Ratio 3.73 %

100 Day SMA 1,354 Rs.

200 Day SMA 1,351 Rs.

21 Day SMA 821 Rs.

50 Day SMA 1,020 Rs.

Book Value 240 Rs.

EV/EBITDA Ratio 22

QoQ EPS Growth -7 %

QoQ Operating Profit Growth -11 %

QoQ Sales Growth -2 %

Sales Latest Quarter 217 Cr.

YoY Sales Growth -1 %

Market Cap. ₹3,654 Cr.

52 Week - High/Low ₹1,997/718

P/E Ratio 32.64

P/B Ratio 3.12

Enterprise Value ₹3,511 Cr.

ROE % 10.23

RSI Value 26.16

EMA 50 1010.03

EMA 200 1228.06

Net Profit 92 Cr.

Net Profit 3year growth 6.17 Cr.

Net Profit 3 year (back) -117 Cr.

Debt to Equity 0.12 %

EPS Growth TTM -17.71 %

Current Ratio 3.04 %

100 Day SMA 1,354 Rs.

200 Day SMA 1,351 Rs.

21 Day SMA 821 Rs.

50 Day SMA 1,020 Rs.

Book Value 231 Rs.

EV/EBITDA Ratio 23

QoQ EPS Growth -24 %

QoQ Operating Profit Growth -22 %

QoQ Sales Growth -2 %

Sales Latest Quarter 217 Cr.

YoY Sales Growth -1 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages